echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Hebei Province Solicits Opinions on the Implementation Rules for the Management of Traditional Chinese Medicine Formula Granules

    Hebei Province Solicits Opinions on the Implementation Rules for the Management of Traditional Chinese Medicine Formula Granules

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 8, the Hebei Provincial Food and Drug Administration issued a notice on the public solicitation of "Hebei Province Traditional Chinese Medicine Formula Granule Management Implementation Rules" (Draft for Comment), and the deadline was September 24
    .

    The original text is as follows:
     Notice of the Hebei Provincial Drug Administration on the public solicitation of "Hebei Province Traditional Chinese Medicine Formula Granules Management Implementation Rules" (Consultation Draft)
    to relevant departments: To implement the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine , and the National Health and Health Administration The “Announcement on Ending the Pilot Work of TCM Formula Granules” (No.
    22 of 2021) jointly issued by the Commission and the National Medical Insurance Administration.
    Open for comments
    .
    Please send your comments and suggestions to the email address zhy20050131@sina.
    com before September 24
    .
    Attachment: "Implementation Rules for the Management of Traditional Chinese Medicine Granules in Hebei Province" (Draft for Solicitation of Comments).
    docx Hebei Provincial Drug Administration September 7, 2021 (Type of Information Disclosure: Disclosure upon application) Copy: relevant departments and directly affiliated institutions Unit
    .

      Implementation Rules for the Management of Traditional Chinese Medicine Granules in Hebei Province
      (Draft for Solicitation of Comments)
      Chapter 1 General Provisions Article
    1 is to strengthen the management of traditional Chinese medicine granules, guide the healthy development of the industry, better meet the clinical needs of Chinese medicine, and implement the "National Chinese Medicine Announcement of the National Health Commission and the National Medical Insurance Bureau of the State Administration of Medicine on Ending the Pilot Work of TCM Formula Granules (No.
    22 of 2021), in accordance with the “Pharmaceutical Administration Law of the People’s Republic of China”, “Traditional Chinese Medicine Law” and “Implementation Regulations of the Drug Administration Law of the People’s Republic of China” ", formulate these rules
    .
    Article 2 These rules apply to the implementation of management of Chinese medicine formula granules produced, sold and used in Hebei Province
    .
    Article 3 Traditional Chinese medicine formula granules are granules made from single-flavored Chinese medicine pieces through water extraction, separation, concentration, drying, and granulation.
    Under the guidance of Chinese medicine theory, they are formulated in accordance with clinical prescriptions of Chinese medicine and then used by patients
    .
    The quality supervision of TCM formula granules is included in the management of TCM decoction pieces
    .
    Article 4 The Provincial Drug Administration is responsible for the supervision and management of Hebei Province’s standard formulation, filing management, production and entrusted distribution of traditional Chinese medicine formula granules
    .
    The Provincial Health Commission and the Provincial Administration of Traditional Chinese Medicine are responsible for researching and formulating relevant policies for the clinical use of traditional Chinese medicine formula granules in Hebei Province and conducting supervision and management
    .
    The Provincial Medical Security Bureau is responsible for the bidding and procurement of traditional Chinese medicine formula granules in Hebei Province , and medical insurance payment and other related work, as well as supervision and inspection
    .
    Each city and county market supervision bureau is responsible for the quality supervision and management of the use of traditional Chinese medicine granules in medical institutions within its jurisdiction
    .

      Chapter 2 Production Management
    Article 5 A Chinese medicine production enterprise that produces Chinese medicine formula granules shall meet the following conditions: (1) It shall be established in accordance with the law in China and be able to independently assume responsibility (including the ability to bear responsibility for drug quality and safety)
    .
    (2) Obtain the "Drug Production License", and also have the scope of production of Chinese medicine decoction pieces and granules, and comply with the relevant requirements of the "Pharmaceutical Manufacturing Practices" (GMP)
    .
    (3) It has the complete production capacity of processing, extraction, separation, concentration, drying, and granulation of Chinese herbal medicine pieces, and has a production scale corresponding to the number of varieties produced and sold
    .
    (4) It has supporting quality management rules and regulations, a complete drug quality assurance system, and quality management capabilities such as product release and recall
    .
    (5) Establish specialized drug monitoring and evaluation institutions and full-time personnel, establish a drug monitoring and evaluation system, have the ability to implement risk management on drugs, and undertake the obligations of drug adverse drug reaction monitoring, risk-benefit evaluation, and risk control in accordance with the law, and be responsible for the establishment and maintenance of drugs Adverse reaction monitoring system manages drug monitoring and evaluation
    .
    (6) The number of varieties developed by the production enterprise should exceed 400
    .
    Article 6 The production enterprise of Chinese medicine formula granules shall fulfill the main responsibility and related obligations of the whole life cycle of the medicine, establish a traceability system, realize the source can be checked, whereabouts can be traced, and strengthen risk management
    .
    Article 7 The manufacturing enterprise shall cooperate with the supervision work of the drug supervision and administration department, cooperate with the inspection organized and implemented by the drug supervision and administration department, and shall not refuse, evade or obstruct
    .
    Article 8 Traditional Chinese medicine formula granules shall be produced in accordance with the recorded production process and meet the national drug standards
    .
    If there is no provision in the national drug standards, it shall comply with the standards established by the provincial drug regulatory authority
    .
    Article 9 The base of Chinese medicinal materials, the processing method of the place of origin, and the storage and logistics enterprises shall be fixed
    .
    The Chinese medicinal materials required for the production of Chinese medicinal granules that can be artificially planted and bred shall be given priority to use Chinese medicinal materials derived from Chinese medicinal materials planting and breeding bases that meet the requirements of the Chinese medicinal material production quality management regulations in the local area
    .
    Chinese medicine prescription granules are fed with Chinese medicine decoction pieces, and the Chinese medicine decoction pieces used in the production of Chinese medicine prescription granules shall be processed by themselves
    .
    Article 10 The production enterprise shall verify the extraction, separation, concentration, and drying processes to clarify the methods, parameters and conditions of the extraction, filtration, or centrifugation, such as solid-liquid separation, concentration, drying, and molding steps
    .
    The manufacturer should determine the reasonable composition of the preparation through research and clarify the type and dosage range of excipients
    .
    The excipients used in the production shall meet the requirements for medicinal use and the requirements of the corresponding production quality management regulations
    .
    The production process regulations and standard operating procedures for controlling product quality shall be formulated according to the recorded production process, and complete batch production and inspection records shall be established.

    .
    Article 11 The label of direct contact with the packaging of Chinese medicine formula granules shall at least indicate the record number, name, execution standards of Chinese medicine preparations, execution standards of Chinese medicine formula granules, specifications, production date, product batch number, shelf life, storage, manufacturer, production address, and contact.
    Ways and other content
    .
    Materials that directly contact the granules of traditional Chinese medicine formulations should meet the requirements for medicinal use
    .
    Article 12 A manufacturing enterprise may set up a pre-processing or extraction workshop in a different place, or share a pre-processing and extraction workshop with a pharmaceutical manufacturer within the group that has a controlling relationship.
    The details are in accordance with the original State Food and Drug Administration’s proposal on strengthening the extraction and extraction of traditional Chinese medicine production.
    The relevant regulations on the supervision and management of extracts shall be implemented
    .
    Article 13 The production enterprise shall have management measures to properly dispose of production waste residues, and strictly prevent the decoction pieces of Chinese medicine extracted by water from entering the market again
    .

      Chapter III Use Management
    Article 14 Chinese medicine formula granules shall not be sold outside medical institutions
    .
    Medical institutions shall not purchase undocumented Chinese medicine formula granules
    .
    The Chinese medicine formula granules used should be purchased through the provincial centralized drug procurement platform Sunshine procurement and online transactions
    .
    Directly distributed by the manufacturer, or by the manufacturer's entrusted configuration with a warehouse management system (WMS), and distribution by a pharmaceutical business enterprise that has storage and transportation conditions
    .
    Enterprises that accept the distribution of Chinese medicine formula granules shall not entrust the distribution
    .
    The medical institution shall sign a quality assurance agreement with the manufacturing enterprise
    .
    Article 15 Medical institutions shall check and accept the purchased Chinese medicine formula granules in accordance with the standards, and those that fail to pass the check and acceptance shall not be used
    .
    The manufacturer should provide the medical institution with a self-inspection report of the traditional Chinese medicine formula granules
    .
    Article 16 The training of medical personnel in the rational use of Chinese medicine formula granules shall be strengthened to avoid unreasonable use of Chinese medicine formula granules
    .
    Medical institutions should take effective measures in the monitoring of adverse reactions and safety risk control of TCM formula granules to ensure the safety of clinical use of TCM formula granules
    .
    Article 17 The dispensing equipment of traditional Chinese medicine formula granules should conform to the clinical practice of traditional Chinese medicine, and effectively prevent errors, pollution and cross-contamination
    .
    The adjustment software used shall be traceable to the adjustment process
    .
    Article 18 Adhere to the dominant position of Chinese herbal medicine pieces
    .
    If the varieties of Chinese herbal medicines have been included in the scope of medical insurance payment, the provincial medical insurance department may comprehensively consider factors such as clinical needs, fund payment ability and price, and after expert review, the Chinese herbal medicine formula particles corresponding to the Chinese herbal medicines shall be included in the payment scope, and refer to the category B management
    .

      Chapter IV Drug Standards
    Article 19 The quality standards of traditional Chinese medicine formula granules are divided into national standards and Hebei province standards
    .
    Hebei Provincial Drug Administration in accordance with "Technical Requirements for Quality Control and Standard Establishment of Traditional Chinese Medicine Granules in Hebei Province" (for trial implementation), "Working Procedures for Supplementing the Quality Standards for Traditional Chinese Medicine Formula Granules in Hebei Province and Requirements for Application Documents" (for trial implementation) The formulation and revision of standards
    .
    After the national drug standards for Chinese medicine formula granules are promulgated and implemented, the corresponding standards formulated by the provincial drug supervision and management departments shall be abolished
    .
    If Chinese medicine formula granules without national drug standards are used in Hebei Province, they shall meet the quality standards of Hebei Province Chinese medicine formula granules
    .
    Research institutions and manufacturers that carry out scientific research on the standards of traditional Chinese medicine formula granules can provide research data and quality standards to the Hebei Provincial Drug Administration as required
    .
    Article 20 The formulation of the quality standards of traditional Chinese medicine formula granules should be compared with standard decoctions, and the consistency with the basic properties of Chinese medicine decoction pieces and the peculiarities of the lack of traits should be fully considered.
    Factors that affect quality in all aspects of production and use, strengthen specific identification and multi-component, overall quality control, and fully reflect the advanced level of drug quality control at this stage
    .
    The format and terminology of the quality standard of Chinese medicine formula granules should refer to the "Pharmaceuticals of the People's Republic of China", and its contents mainly include: name, source, preparation method, properties, identification, characteristic map or fingerprint map, inspection, extract, content determination, specification ( particles per gram of the formulation of an amount equivalent to Pieces), storage and the like
    .
    The description of the preparation process should include the entire process, the main process parameters, the range of the paste rate, the auxiliary materials and their dosages, and the production volume
    .
    The limits or content of pesticide residues, heavy metals and harmful elements, mycotoxins and endogenous toxic and harmful ingredients should be studied
    .

      Chapter V Filing and Supervision and Administration
    Article 21 The Chinese medicine formula granules shall be subject to filing management, and the production enterprises in Hebei Province shall file for filing before listing
    .
    Production enterprises that have obtained production licenses in Hebei Province and those that sell cross-border in Hebei Province shall log in to the "Registration Management Module of Traditional Chinese Medicine Formula Granules of the Pharmaceutical Business Application System of the State Drug Administration" in accordance with the requirements of the State Drug Administration (hereinafter referred to as (Referred to as the filing platform of Chinese medicine formula granules) for filing
    .
    The manufacturer shall be responsible for the authenticity, completeness and traceability of the materials submitted for record, and shall bear corresponding legal responsibilities
    .
    Where there are changes to the registered TCM formula granules, the content in the record information sheet and the product technical requirements for the record, the record manufacturer shall make record changes to the original record department in accordance with the procedures and requirements stipulated by the State Drug Administration
    .
    Production enterprises that have been put on record shall submit annual reports in accordance with the requirements
    .
    If the record is not carried out in accordance with the requirements, the Provincial Drug Administration shall deal with it in accordance with the law
    .
    Article 22 The drug supervision and administration department shall strengthen the supervision during and after the event, strengthen inspection, random inspection and monitoring, and may carry out extended inspections on the sources of Chinese medicinal materials and inter-provincial (regional, municipal) workshops or shared workshops in different places.
    Production and medical institutions use traditional Chinese medicine formula granules to conduct supervision and random inspections, and make the inspection and inspection results public to the public
    .
    Article 23 Smooth reporting and complaint channels
    .
    Any unit or individual has the right to report violations of laws and regulations discovered in the development, production, filing, sales, use, and medical insurance payment of Chinese medicine formula granules to relevant functional departments, and relevant functional departments shall verify and deal with them in a timely manner
    .
    Article 24 If there are other regulations in the state for the administration of granules of traditional Chinese medicine prescriptions, those regulations shall prevail
    .
    Each department may formulate relevant supplementary requirements in accordance with their responsibilities and relevant laws, regulations , and regulatory documents
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.